跳至主要内容
临床试验/NCT05743673
NCT05743673招募中不适用

A Feasibility Study of the SHAPE™ Test of Aerobic Fitness in Older Adults Presenting for Moderate to High-risk Surgery

Yale University2 个研究点 分布在 1 个国家目标入组 371 人开始时间: 2023年5月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
371
试验地点
2
主要终点
Recruitment Success

研究概览

简要总结

This study is looking at whether a simplified exercise test called the SHAPE-HF cardiopulmonary testing system can be used before surgery in older adults. Doctors often need to know how well a patient's heart, lungs, and body handle physical activity before moderate- to high-risk surgery. This information may help them better understand a patient's fitness for surgery and possible risk of complications afterward.

The study will enroll adults older than 60 years who are being evaluated before planned moderate- to high-risk noncardiac surgery. The first goal is to determine if this was feasible in older adults and to learn whether patients can be successfully recruited to complete this pre-surgery test. Secondly, the study will also look at how results from the SHAPE-HF system compare with common ways doctors now estimate fitness, such as asking patients about their physical activity and using a standard questionnaire.

Participants will attend one in-person study visit lasting about 35 minutes. During that visit, they will answer questions about their activity level and complete testing with the SHAPE-HF system. The test uses short periods of lower-intensity exercise to estimate aerobic fitness. After the visit, participants will be contacted by phone about 24 hours later to check for any problems related to the study test.

Lastly, researchers will also review information from the medical record for 30 days after surgery to see whether test results are related to recovery, short-term health problems after surgery, or major complications. No extra surgery or change in planned medical care is part of this study. The information learned may help improve how doctors evaluate older adults before surgery in the future.

详细描述

Preoperative functional capacity is a central component of perioperative risk assessment in older adults undergoing moderate- to high-risk surgery. Reduced cardiopulmonary reserve is associated with increased postoperative morbidity, prolonged recovery, and major adverse cardiovascular events, yet functional capacity in routine practice is often estimated using subjective measures such as self-reported activity tolerance, MET estimates, and questionnaire-based assessment. These tools are practical but may misclassify physiologic fitness, particularly in older adults who report acceptable activity levels despite diminished aerobic reserve.

Objective cardiopulmonary exercise testing can provide more precise assessment, but widespread use is limited by the complexity and burden of conventional testing. The SHAPE-HF cardiopulmonary testing system is an FDA-approved simplified submaximal exercise testing platform intended to provide objective assessment of aerobic fitness in a manner that may be more feasible for routine use in a preoperative clinic.

Conventional cardiopulmonary exercise testing can provide objective assessment of aerobic capacity, but broad implementation is often limited by time, workflow, equipment, and patient burden. The SHAPE-HF cardiopulmonary testing system is an FDA-approved simplified submaximal cardiopulmonary exercise testing platform designed to generate objective physiologic measures of aerobic fitness using abbreviated exercise testing. This approach may offer a more practical method for assessing functional capacity in a high-volume preoperative clinic while reducing the burden associated with traditional maximal exercise testing.

This study is a prospective, single-site, non-randomized investigation evaluating the use of the SHAPE-HF cardiopulmonary testing system in adults older than 60 years who are undergoing preoperative evaluation before moderate- to high-risk surgery. The study population includes patients with a Revised Cardiac Risk Index (RCRI) score less than 4 and self-reported functional capacity greater than 4 METs who otherwise meet protocol-defined eligibility criteria. This population was selected because many such patients would typically be considered to have acceptable functional status by standard preoperative screening, yet some may still have unrecognized limitations in aerobic capacity and increased perioperative risk.

The study has been modified over time to support progressively broader scientific aims. It was initially conducted as a technical proof-of-concept study enrolling 42 participants to evaluate implementation of simplified submaximal cardiopulmonary exercise testing in the preoperative setting. The protocol was subsequently modified to a feasibility study with a planned enrollment of 101 participants to evaluate recruitment, workflow integration, and practical use of the SHAPE-HF system in an older surgical population. The study has now been further expanded to a total planned enrollment of 371 participants in order to better evaluate perioperative complications and the relationship between submaximal cardiopulmonary exercise testing performance and postoperative outcomes, and to provide adequate statistical power to identify associations with major adverse perioperative events.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged >60 years
  • Scheduled for pre-surgical evaluation for moderate to high-risk surgical procedure.
  • RCRI <2 based on screening of preoperative co-morbidities.
  • Provision of signed and dated informed consent form

排除标准

  • Age <60 years old
  • Subjective METS <4
  • Inability to give independent informed consent
  • Revised Cardiac Risk Index (RCRI) >2
  • Neurological impairment with motor limitations
  • Mental impairment leading to inability to cooperate
  • Recent NSTEMI or STEMI type myocardial infarction (within 6 months)
  • Angina (stable or unstable, within 6 months)
  • Uncorrected severe valvular heart disease (severe aortic, tricuspid, or mitral stenosis)
  • Recent exacerbation of congestive heart failure (requiring hospitalization, within 6 months)
  • Acute pulmonary embolism or deep vein thrombosis (within past 6 months)
  • Uncontrolled pulmonary edema
  • Uncontrolled symptomatic arrhythmias
  • Active endocarditis
  • Acute myocarditis or pericarditis
  • Active wheezing or home oxygen use
  • Recent exacerbation of chronic obstructive pulmonary disease or asthma or pneumonia (requiring hospitalization, within 6 months)
  • Inability to perform components of the SHAPE test (severe hip flexion limitation, severe osteoarthritis of knee or hip, limb immobilization, ambulation with a walker, can or crutches, baseline balance irregularities
  • Diagnosis of vertigo
  • Known allergic reactions to components of the SHAPE medical system apparatus disposable mouthpiece.
  • Active enrollment in an interventional clinical trial within the enrollment period of the study.

研究组 & 干预措施

Validation Cohort

Older subjects (>60 years old) presenting for moderate to high-risk surgical procedure with reported subjective metabolic equivalents of >4 METS and with a score of <4 on the revised cardiac risk index (RCRI) undergoing submaximal exercise testing.

干预措施: Shape II (Device)

结局指标

主要结局

Recruitment Success

时间窗: 0-30 days

The primary objective for the study is a study enrollment rate of 25% of eligible candidates. Within the parameters of a feasibility study, the following questions will also be addressed: * Physical capacity of clinic to handle the number of participants in the study. * Adequate communication and time frame to efficiently perform abbreviated cardiopulmonary exercise testing in high-volume preoperative testing environment. * Adequate software and hardware to capture and use data obtained from abbreviated cardiopulmonary exercise testing. * Determination of adequate institutional, departmental and clinical support to maintain and perform abbreviated cardiopulmonary exercise testing as an adjunct for preoperative testing. * Does abbreviated cardiopulmonary testing in a preoperative testing environment improve access to care in a diverse and at-risk surgical population

次要结局

  • Conventional measure of metabolic equivalents (METS)(0-1 day)
  • Major postoperative outcomes(0-30 days)
  • Perioperative Morbidity Survey(0-30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zyad Carr

Associate Professor, Department of Anesthesiology

Yale University

研究点 (2)

Loading locations...

相似试验